Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 441397)

Published in Cardiovasc Diabetol on June 18, 2004

Authors

Mike Sampson1, Isabel Davies, Jelena Gavrilovic, Brendan Sussams, Jackie Brown, Sian Astley, David A Hughes

Author Affiliations

1: Bertram Diabetes Research Unit, Norfolk and Norwich University Hospital NHS Trust, Norwich, NR1 3SR, UK. mike.sampson@nnuh.nhs.uk

Articles cited by this

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest (1994) 7.25

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet (1999) 6.76

Oxidative stress and diabetic vascular complications. Diabetes Care (1996) 5.97

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care (1998) 3.34

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care (2000) 2.59

Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun (1992) 2.25

Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol (2002) 2.23

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia (2001) 2.12

Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis (1998) 1.88

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci (1999) 1.68

Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules. J Clin Endocrinol Metab (2000) 1.56

Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients. Diabetes Care (1999) 1.53

Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene (2002) 1.42

Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol (2002) 1.32

Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation (2000) 1.27

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes (2000) 1.27

The postprandial state and risk of cardiovascular disease. Diabet Med (1998) 1.23

Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones (1997) 1.21

Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem (1992) 1.18

Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med (1997) 1.11

Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation (1999) 1.09

Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res (1998) 1.08

Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism (1999) 1.08

A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. J Clin Invest (1995) 1.05

Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. Atherosclerosis (2003) 1.04

Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med (2001) 1.02

Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. Br J Dermatol (2003) 0.95

Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol (2002) 0.91

Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia (1995) 0.90

Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J Immunol (1998) 0.90

Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. Involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform. J Immunol (1995) 0.87

Plasma MMP-9 - a marker of carotid plaque instability. Eur J Vasc Endovasc Surg (2001) 0.85

Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples. Proc Soc Exp Biol Med (1999) 0.85

Platelets adhering to the vascular wall mediate postischemic leukocyte-endothelial cell interactions in retinal microcirculation. Invest Ophthalmol Vis Sci (2004) 0.84

Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy. Diabet Med (2001) 0.84

Monocyte matrix metalloproteinase production in Type 2 diabetes and controls--a cross sectional study. Cardiovasc Diabetol (2003) 0.83

Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. Arterioscler Thromb Vasc Biol (1997) 0.80

Hepatic blood flow during rapid intravenous glucose tolerance test. Res Exp Med (Berl) (1980) 0.79

Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo soluble VCAM-1 release. Diabetologia (1999) 0.78

Articles by these authors

Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care (2006) 2.24

Developing attributes for a generic quality of life measure for older people: preferences or capabilities? Soc Sci Med (2005) 2.16

Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res (2005) 1.77

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics (2005) 1.62

Methylation changes at NR3C1 in newborns associate with maternal prenatal stress exposure and newborn birth weight. Epigenetics (2012) 1.36

Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'. Photochem Photobiol Sci (2006) 1.32

Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid. J Biol Chem (2003) 1.21

Outcome of minimally invasive management of salivary calculi in 4,691 patients. Laryngoscope (2009) 1.20

Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care (2002) 1.17

The Y-chromosome landscape of the Philippines: extensive heterogeneity and varying genetic affinities of Negrito and non-Negrito groups. Eur J Hum Genet (2010) 1.15

Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. Atherosclerosis (2003) 1.04

Lonizing radiation regulations and the dental practitioner: 3. Quality assurance in dental radiography. Dent Update (2012) 1.00

Synthetic macrocyclic peptidomimetics as tunable pH probes for the fluorescence imaging of acidic organelles in live cells. Angew Chem Int Ed Engl (2005) 0.99

Personality factors and posttraumatic stress: associations in civilians one year after air attacks. J Pers Disord (2003) 0.98

Ionizing radiation regulations and the dental practitioner: 2. Regulations for the use of X-rays in dentistry. Dent Update (2012) 0.98

Quantitative PCR for DNA identification based on genome-specific interspersed repetitive elements. Genomics (2004) 0.97

Matrix metalloproteinase genes in Xenopus development. Dev Dyn (2004) 0.97

Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Mol Cancer Res (2008) 0.96

Ionizing radiation regulations and the dental practitioner: 1. The nature of ionizing radiation and its use in dentistry. Dent Update (2012) 0.96

Quantitative intra-short interspersed element PCR for species-specific DNA identification. Anal Biochem (2003) 0.95

Drosophila Rho-kinase (DRok) is required for tissue morphogenesis in diverse compartments of the egg chamber during oogenesis. Dev Biol (2006) 0.94

Fission yeast Dss1 associates with the proteasome and is required for efficient ubiquitin-dependent proteolysis. Biochem J (2006) 0.93

DNA damage and susceptibility to oxidative damage in lymphocytes: effects of carotenoids in vitro and in vivo. Br J Nutr (2004) 0.90

Recent positive selection of a human androgen receptor/ectodysplasin A2 receptor haplotype and its relationship to male pattern baldness. Hum Genet (2009) 0.90

Macrophage migration and invasion is regulated by MMP10 expression. PLoS One (2013) 0.89

Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis (2007) 0.89

Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation. Pharmacoeconomics (2002) 0.88

Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis (2008) 0.87

Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL. Am J Clin Nutr (2003) 0.87

Vitamin D and COPD: seasonal variation is important. Thorax (2010) 0.86

Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects. Atherosclerosis (2004) 0.86

Genetic and neural dissociation of individual responses to emotional expressions in human infants. Dev Cogn Neurosci (2010) 0.86

Alpha-lipoic acid modulates NF-kappaB activity in human monocytic cells by direct interaction with DNA. Exp Gerontol (2002) 0.85

An ancient look at UCP1. Biochim Biophys Acta (2008) 0.84

Monocyte matrix metalloproteinase production in Type 2 diabetes and controls--a cross sectional study. Cardiovasc Diabetol (2003) 0.83

A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro. Biochem Pharmacol (2008) 0.82

Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis (2008) 0.82

Deregulation of the Egfr/Ras signaling pathway induces age-related brain degeneration in the Drosophila mutant vap. Mol Biol Cell (2003) 0.82

Natural selection and the molecular basis of electrophoretic variation at the coagulation F13B locus. Eur J Hum Genet (2008) 0.81

Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control. BMC Endocr Disord (2008) 0.81

Quercetin and its principal metabolites, but not myricetin, oppose lipopolysaccharide-induced hyporesponsiveness of the porcine isolated coronary artery. Br J Pharmacol (2011) 0.81

Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial. Cardiovasc Diabetol (2007) 0.81

p120 Ras GTPase-activating protein associates with fibroblast growth factor receptors in Drosophila. Biochem J (2004) 0.80

Alternatives for the treatment of salivary duct obstruction. Otolaryngol Clin North Am (2009) 0.80

A pilot study of telepractice delivery for teaching listening and spoken language to children with hearing loss. J Telemed Telecare (2014) 0.79

Effect of a beta-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity. Physiol Behav (2004) 0.79

Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes. Cardiovasc Diabetol (2007) 0.79

Focal segmental glomerulosclerosis, Coats'-like retinopathy, sensorineural deafness and chromosome 4 duplication: a new association. Pediatr Nephrol (2010) 0.79

Human metabolic transformation of quercetin blocks its capacity to decrease endothelial nitric oxide synthase (eNOS) expression and endothelin-1 secretion by human endothelial cells. J Agric Food Chem (2013) 0.78

Human quercetin conjugated metabolites attenuate TNF-α-induced changes in vasomodulatory molecules in an HUASMCs/HUVECs co-culture model. Planta Med (2012) 0.77

Fibroblast growth factor 2: A new key player in osteoarthritis. Arthritis Rheum (2009) 0.77

Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy. Diabetes Res Clin Pract (2005) 0.77

Significant presence of terminally differentiated T cells and altered NF-kappaB and I-kappaBalpha interactions in healthy ageing. Exp Gerontol (2004) 0.76

Spectroscopic studies of 1,2-diaminoanthraquinone (DAQ) as a fluorescent probe for the imaging of nitric oxide in living cells. Photochem Photobiol Sci (2007) 0.76

Plant polyphenols: modifiers of immune function and risk of cardiovascular disease. Nutrition (2005) 0.76

Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis. Pediatr Nephrol (2007) 0.75

Advances in the treatment of salivary gland disease. Practitioner (2006) 0.75

Case report--Scanora imaging of an unusual unerupted tooth located entirely below the inferior dental canal. J Ir Dent Assoc (2003) 0.75

Treating posttraumatic stress in post-conflict countries and countries that accepted refugees. Report on the STOP-study, a multi-site study on treatment seeking and treatment outcome in people suffering from posttraumatic stress following war and migration in former Yugoslavia. Med Arh (2004) 0.75

Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data. Pediatr Nephrol (2008) 0.75

Radiation protection: protection of patients undergoing cone beam computed tomography examinations. Dent Update (2010) 0.75